2018 Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Heinicke T Journal Biol Blood Marrow Transplant.
2018 Measurable residual disease, conditioning regimen intensity, and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: A registry analysis of 2292 patients by the Acute Leukemia Working Party European Society of Blood and Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Gilleece MH Journal Am J Hematol.
2018 Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia. Group Acute Leukemia Working Party (ALWP) 1st listed author Battipaglia G Journal Bone Marrow Transplant.
2018 Haploidentical transplantation outcomes for secondary acute myeloid leukemia: Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) study. Group Acute Leukemia Working Party (ALWP) 1st listed author Li Z Journal Am J Hematol.
2018 Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Giebel S Journal Eur J Cancer.
2018 Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Santoro N Journal J Hematol Oncol.
2018 Optimizing the pretransplant regimen for autologous stem cell transplantation in acute myelogenous leukemia: Better outcomes with busulfan and melphalan compared with busulfan and cyclophosphamide in high risk patients autografted in first complete remission: A study from the acute leukemia working party of the EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Gorin NC Journal Am J Hematol.
2018 Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT. Group Acute Leukemia Working Party (ALWP) 1st listed author Ruggeri A Journal J Hematol Oncol.
2018 Impact of Donor Type in Patients with AML Given Allogeneic Hematopoietic Cell Transplantation After Low-Dose TBI-Based Regimen. Group Acute Leukemia Working Party (ALWP) 1st listed author Baron F Journal Clin Cancer Res.
2018 Impact of antithymocyte globulin doses in reduced intensity conditioning before allogeneic transplantation from matched sibling donor for patients with acute myeloid leukemia: a report from the acute leukemia working party of European group of Bone Marrow Transplantation. Group Acute Leukemia Working Party (ALWP) 1st listed author Devillier R Journal Bone Marrow Transplant.
2018 Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse. Group Acute Leukemia Working Party (ALWP) 1st listed author Kharfan-Dabaja MA Journal JAMA Oncol.
2018 Cord blood transplantation is associated with good outcomes in secondary Acute Myeloid Leukaemia in first remission. Group Acute Leukemia Working Party (ALWP) 1st listed author Baron F Journal J Intern Med.